+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Cell"

World Market for Blood Screening, 2022 - Product Thumbnail Image

World Market for Blood Screening, 2022

  • Report
  • January 2022
  • 42 Pages
  • Global
From
From
Hematology Analyzer Market - Product Thumbnail Image

Hematology Analyzer Market

  • Report
  • June 2023
  • 144 Pages
  • Global
From
Global Blood Transfusion and Intravenous Equipment Market - Product Thumbnail Image

Global Blood Transfusion and Intravenous Equipment Market

  • Report
  • April 2022
  • 148 Pages
  • Global
From
From
Cell Harvesting Market - Product Thumbnail Image

Cell Harvesting Market

  • Report
  • May 2019
  • 148 Pages
  • Global
From
Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
From
From
From
Loading Indicator

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions. The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs. Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more